Key Market Indicators
Sales of diabetes medicine in Ireland are predicted to reach $157 million by 2026. This marks an average year-on-year increase of 1.7% since 2013, when the Irish market was worth $143.77 million. Norway topped the 2021 ranking, with Canada, Spain and Italy coming in at numbers 2, 3 and 4 respectively. Irish imports of insulin are expected to hit $37.4 million in 2026, with an average year-on-year growth of 1.7% since 1997. Exports of Irish insulin decreased by 37.5% in 2021 compared to the year before, totalling $127,840. This marks a 12.1% year-on-year drop since 1998, with Finland leading the 2021 ranking, followed by France, Italy and China in positions 2, 3 and 4.
